Bavarian Wins US Order for 2.5 Million More Monkeypox Shots (3)

Bavarian Nordic A/S, the only company with an approved vaccine specifically for monkeypox, won another order from the US government as the virus continues to spread.

The Danish drugmaker will supply 2.5 million doses of Jynneos vaccine to US authorities in the last quarter of the year and in 2023, the Department of Health and Human Services said Friday in a statement. The order brings the total number of doses to be delivered this year and next to more than 4 million, HHS said. Bavarian’s shares rose 3.9% in Copenhagen.

There were 396 US monkeypox cases as of ...